Skip to Content
Stock Analyst Update

Cannabis Stocks Rally from Senate Results

Despite the rally, actual economic exposure differs widely.

Mentioned: , , , , ,

On Jan. 5, Georgia held runoff elections for its two Senate seats. Major news outlets have called the election for the Democrats, ousting both Republican incumbents and leaving the Senate evenly split. Under a 50-50 split, Vice President-elect Kamala Harris would cast the tiebreaking vote, effectively giving control to Democrats. With control of the White House and both chambers of Congress, President-elect Biden has received an accommodative path for his agenda.

Following the results, cannabis stocks rallied by mid-single-digit to midteens percentages amid optimism for federal legalization. Since the beginning of November, the sector has rallied massively by 40% to 150%, far outpacing the market’s own impressive 14% return.

For U.S. federal legalization, U.S. multistate operators Curaleaf (CURLF) and Green Thumb (GTBIF) have the most economic exposure, though we see them as fairly valued following the massive rally. Only Canadian producers Aphria (APHA), Aurora (ACB), and Tilray (TLRY) look undervalued, but these companies lack economic exposure to U.S. THC markets.

We continue to believe that federal legalization will take place by the end of 2023, most likely in the form of states’ rights that allow each state to decide legalization for recreational and medical cannabis. Still, we’d caution investors on the election result.

First, even with a Democratic-controlled Senate, major cannabis legislation would likely require 60 votes. This creates some uncertainty around the timing and form of any potential legalization.

Second, except for Canopy’s (CGC) standing deal to acquire Acreage, Canadian producers have no THC exposure to the U.S. market. Nevertheless, these stocks have rallied massively from election results. In reality, the Canadian companies would have to acquire or build a presence in the U.S. Meanwhile, U.S. producers like Curaleaf and Green Thumb continue to build a strong competitive position. The longer it takes for U.S. federal law to change, the harder it will be for Canadians to enter and effectively compete.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Kristoffer Inton does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.